Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/40141
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Verleye, Arno | - |
dc.contributor.author | Wijtvliet, Veerle | - |
dc.contributor.author | ABRAMS, Steven | - |
dc.contributor.author | Hellemans, Rachel | - |
dc.contributor.author | Bougrea, Rania | - |
dc.contributor.author | Massart, Annick | - |
dc.contributor.author | Pipeleers, Lissa | - |
dc.contributor.author | Wissing, Karl Martin | - |
dc.contributor.author | Ariën, Kevin K | - |
dc.contributor.author | De Winter, Benedicte Y | - |
dc.contributor.author | Van Damme, Pierre | - |
dc.contributor.author | Abramowicz, Daniel | - |
dc.contributor.author | Ledeganck, Kristien J | - |
dc.date.accessioned | 2023-05-24T08:50:13Z | - |
dc.date.available | 2023-05-24T08:50:13Z | - |
dc.date.issued | 2022 | - |
dc.date.submitted | 2023-05-22T14:32:06Z | - |
dc.identifier.citation | Nephrology, dialysis, transplantation, 37 (8) , p. 1566 -1575 | - |
dc.identifier.uri | http://hdl.handle.net/1942/40141 | - |
dc.description.abstract | Background.Inthegeneralpopulation,theseroconversion rateafterprimaryvaccinationwithtwodosesofanantisevereacuterespiratorysyndromecoronavirus2messenger RNA(mRNA)vaccinereachesnearly100%,withsignificantly higherantibodytitersaftermRNA-1273vaccinationcompared toBNT162b2vaccination.Hereweperformedasystematic reviewandmeta-analysistocomparetheantibodyresponse aftertwo-dosemRNA-1273versusBNT162b2vaccinationin solidorgantransplant(SOT)recipients. Methods.Asystematicliteraturereviewwasperformedusing PubMed,WebofScienceandtheCochraneLibraryand originalresearchpaperswereincludedforameta-analysisto calculatevaccine-specificseroconversionratesforeachofthe mRNAvaccines.Next,thepooledrelativeseroconversionrate wasestimated. Results.Eightstudiesthatdescribedthedevelopmentofantibodiesagainstreceptor-bindingdomain(RBD)and/orspike proteinwereeligibleformeta-analysis.Twoofthesestudies alsoreportedantibodytiters.Themeta-analysisrevealedlower seroconversionratesinSOTrecipientsvaccinatedwithtwo dosesofBNT162b2{44.3%[95%confidenceinterval(CI) 34.1–54.7]}ascomparedwithpatientsvaccinatedwithtwo dosesofmRNA-1273[58.4%(95%CI47.2–69.2)].Therelative seroconversionratewas0.795(95%CI0.732–0.864). Conclusions.Thissystematicreviewandmeta-analysis indicatesthatinSOTrecipients,higherseroconversionrates wereobservedaftervaccinationwithmRNA-1273compared withBNT162b2. | - |
dc.description.sponsorship | Nofundingwasreceivedtoassistwiththepreparationofthis manuscript. TheauthorswouldliketothankErikSneldersforhis outstandingsecretarialhelp. | - |
dc.language.iso | en | - |
dc.publisher | - | |
dc.rights | The Author(s) 2022.Published by Oxford University Presson behalf of the ERA. Allrights reserved. For permissions, please e-mail: journals.permissions@oup.com. Free access | - |
dc.title | Seroconversion rate after primary vaccination with two doses of BNT162b2 versus mRNA-1273 in solid organ transplant recipients: a systematic review and meta-analysis | - |
dc.type | Journal Contribution | - |
dc.identifier.epage | 1575 | - |
dc.identifier.issue | 8 | - |
dc.identifier.spage | 1566 | - |
dc.identifier.volume | 37 | - |
local.format.pages | 10 | - |
local.bibliographicCitation.jcat | A1 | - |
local.type.refereed | Refereed | - |
local.type.specified | Article | - |
dc.identifier.doi | 10.1093/ndt/gfac174 | - |
local.provider.type | CrossRef | - |
local.uhasselt.international | no | - |
item.fulltext | With Fulltext | - |
item.contributor | Verleye, Arno | - |
item.contributor | Wijtvliet, Veerle | - |
item.contributor | ABRAMS, Steven | - |
item.contributor | Hellemans, Rachel | - |
item.contributor | Bougrea, Rania | - |
item.contributor | Massart, Annick | - |
item.contributor | Pipeleers, Lissa | - |
item.contributor | Wissing, Karl Martin | - |
item.contributor | Ariën, Kevin K | - |
item.contributor | De Winter, Benedicte Y | - |
item.contributor | Van Damme, Pierre | - |
item.contributor | Abramowicz, Daniel | - |
item.contributor | Ledeganck, Kristien J | - |
item.fullcitation | Verleye, Arno; Wijtvliet, Veerle; ABRAMS, Steven; Hellemans, Rachel; Bougrea, Rania; Massart, Annick; Pipeleers, Lissa; Wissing, Karl Martin; Ariën, Kevin K; De Winter, Benedicte Y; Van Damme, Pierre; Abramowicz, Daniel & Ledeganck, Kristien J (2022) Seroconversion rate after primary vaccination with two doses of BNT162b2 versus mRNA-1273 in solid organ transplant recipients: a systematic review and meta-analysis. In: Nephrology, dialysis, transplantation, 37 (8) , p. 1566 -1575. | - |
item.accessRights | Open Access | - |
item.validation | vabb 2024 | - |
crisitem.journal.issn | 0931-0509 | - |
crisitem.journal.eissn | 1460-2385 | - |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Seroconversion rate after primary vaccination with two doses of BNT162b2 versus mRNA-1273.pdf | Published version | 772.2 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.